Corcept Therapeutics Aktie
76,94
EUR
+0,40
EUR
+0,52
%
89,00
USD
-1,27
USD
-1,41
%
Werbung
Corcept Therapeutics Aktie Analyse
04.02.19 | Corcept Therapeutics Neutral | B. Riley FBR | |
10.08.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
31.05.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
09.03.18 | Corcept Therapeutics Buy | B. Riley FBR, Inc. | |
31.08.17 | Corcept Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
21.04.15 | Corcept Therapeutics Outperform | FBR Capital | |
02.11.09 | Corcept Therapeutics kaufen | Global Biotech Investing | |
28.08.06 | Corcept Therapeutics Market Perform | Punk, Ziegel & Co | |
Werbung
|
|||
15.08.05 | Corcept Therapeutics Buy | Punk, Ziegel & Co | |
25.04.05 | Corcept Therapeutics Outperform | Harris Nesbitt |
Werbung
Werbung